Interplay between Notch1 and Notch3 promotes EMT and tumor initiation in squamous cell carcinoma

Mitsuteru Natsuizaka(Hokkaido University), Kelly A. Whelan(Sidney Kimmel Cancer Center), Shingo Kagawa(Chiba University), Koji Tanaka(Osaka Gakuin University), Véronique Giroux(Sidney Kimmel Cancer Center), Prasanna M. Chandramouleeswaran(Sidney Kimmel Cancer Center), Apple Long(Sidney Kimmel Cancer Center), Varun Sahu(Sidney Kimmel Cancer Center), Douglas S. Darling(University of Louisville), Jianwen Que(Columbia University), Yizeng Yang(Sidney Kimmel Cancer Center), Jonathan P. Katz(Sidney Kimmel Cancer Center), E. Paul Wileyto(Sidney Kimmel Cancer Center), Devraj Basu(Sidney Kimmel Cancer Center), Yoshiaki Kita(Kagoshima University), Shoji Natsugoe(Kagoshima University), Seiji Naganuma(Kōchi University), Andres J. Klein–Szanto(Fox Chase Cancer Center), J. Alan Diehl(Medical University of South Carolina), Adam J. Bass(Harvard University), Kwok‐Kin Wong(Harvard University), Anil K. Rustgi(University of Pennsylvania), Hiroshi Nakagawa(University of Pennsylvania)
Nature Communications
November 20, 2017
Cited by 205Open Access
Full Text

Abstract

Notch1 transactivates Notch3 to drive terminal differentiation in stratified squamous epithelia. Notch1 and other Notch receptor paralogs cooperate to act as a tumor suppressor in squamous cell carcinomas (SCCs). However, Notch1 can be stochastically activated to promote carcinogenesis in murine models of SCC. Activated form of Notch1 promotes xenograft tumor growth when expressed ectopically. Here, we demonstrate that Notch1 activation and epithelial-mesenchymal transition (EMT) are coupled to promote SCC tumor initiation in concert with transforming growth factor (TGF)-β present in the tumor microenvironment. We find that TGFβ activates the transcription factor ZEB1 to repress Notch3, thereby limiting terminal differentiation. Concurrently, TGFβ drives Notch1-mediated EMT to generate tumor initiating cells characterized by high CD44 expression. Moreover, Notch1 is activated in a small subset of SCC cells at the invasive tumor front and predicts for poor prognosis of esophageal SCC, shedding light upon the tumor promoting oncogenic aspect of Notch1 in SCC.


Related Papers

No related papers found

Powered by citation graph analysis